Bharat Book Bureau Provides the Trending Market Research Report on Global Retinal Vein Occlusion Market Opportunity Analysis And Industry Forecast 2023 under Life Science category. Retinal Vein Occlusion Market Information: By Types (Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion), Condition (Non-Ischemic and Ischemic), Diagnosis (Optical Coherence Tomography), Treatment and End-User – Global Forecast till 2023
Retinal Vein Occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. However, it is the second most common cause of vision loss from retinal vascular disease after diabetic retinopathy. The market for retinal vein occlusion is expected to grow at an exponential rate owing to an increasing prevalence of eye diseases and chronic diseases such as diabetes, which are major risk factors for eye disease. Furthermore, rising demand for better treatment methods for eye diseases is fueling the market growth. Consequently, the majority of the market players have a great opportunity in this market as they use strategic approaches such as geographical expansion.
The retinal vein occlusion market is changing continuously during the last few decades and is expecting a huge development in coming future. Through extensive research, it is found that the market players have adopted the strategy of FDA approvals and acquisitions to expand their market. The key players involved in this strategy are Allergan, Bayer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Ellex Medical Lasers, GlaxoSmithKline Plc, IRIDEX Corporation. FDA approvals (25%) was the most widely adopted strategy which was adopted by the key market players. The number of key market players involved in distribution agreement (30%), collaboration (15%) and clinical trials (10%), and others were comparatively low. The market players which were involved in others are Novartis, Quantel Medical Inc, Topcon Medical Systems, Inc., and ZEISS among others in the global retinal vein occlusion market.
Request a free sample copy of Retinal Vein Occlusion Market Report @
However, high cost and side-effects associated with the treatment may affect the growth of the global retinal vein occlusion market negatively.
The global retinal vein occlusion market is expected to grow at a CAGR of 11.2% during the forecast period 2017-2023.
- Pharmaceutical Companies
- Medical Devices Companies
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
- The global retinal vein occlusion market was estimated to USD 7,557.52 million in 2016
- Fundoscopic examination is the fastest growing segment, which is projected to grow at a CAGR of 11.6% during the forecast period from 2017-2023
- The Americas has captured the largest market globally and is expected to reach USD 6,018.16 million by 2023
- Asia Pacific is the fastest growing region across the globe and expected to grow at a rate of CAGR 11.4% during the forecast period
The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.
Europe holds the second position in the market owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current health care expenditure of EUR 237 billion.
Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and China. These countries are encouraging the growth of the retinal vein occlusion market.-
The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare sector and developing medical facilities, which will boost the market of this region.
Some of the key players in this market are Allergan, Bayer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Ellex Medical Lasers, GlaxoSmithKline Plc, IRIDEX Corporation, Novartis, Quantel Medical Inc, Topcon Medical Systems, Inc., ZEISS, Lumenis, Sanofi Aventis, Valeant Pharmaceuticals, Alimera Sciences, Fovea Pharmaceuticals SA, Icon Biosciences, Suzuken Co.Ltd, Genentech, Inc., Ranbaxy Pharmaceuticals, Johnson & Johnson Services, Inc, Teva Pharmaceutical, Pfizer Inc., Astrazeneca, Aerpio Therapeutics Inc, Annexin Pharmaceuticals AB and others.
Browse our full report with Table of Contents :
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.